Abdulkarim Abdulrahman

807 total citations
22 papers, 353 citations indexed

About

Abdulkarim Abdulrahman is a scholar working on Infectious Diseases, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Abdulkarim Abdulrahman has authored 22 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 4 papers in Neurology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Abdulkarim Abdulrahman's work include COVID-19 Clinical Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Long-Term Effects of COVID-19 (4 papers). Abdulkarim Abdulrahman is often cited by papers focused on COVID-19 Clinical Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Long-Term Effects of COVID-19 (4 papers). Abdulkarim Abdulrahman collaborates with scholars based in Bahrain, United States and United Kingdom. Abdulkarim Abdulrahman's co-authors include Manaf AlQahtani, Stephen L. Atkin, Saad I. Mallah, Sameer Otoom, Nigel J. Stevenson, Ronán Conroy, Ali A. Rabaan, Omar Yaghi, Simone Perna and Essam M. Janahi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and British Journal of Ophthalmology.

In The Last Decade

Abdulkarim Abdulrahman

19 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdulkarim Abdulrahman Bahrain 11 263 60 57 35 34 22 353
Han-Ping Huang China 2 260 1.0× 51 0.8× 20 0.4× 125 3.6× 21 0.6× 3 365
Xufang Bai Canada 5 203 0.8× 25 0.4× 68 1.2× 65 1.9× 18 0.5× 7 389
Adam Lee United States 8 157 0.6× 31 0.5× 36 0.6× 10 0.3× 11 0.3× 32 359
Suzanne Arinsburg United States 10 154 0.6× 21 0.3× 27 0.5× 121 3.5× 23 0.7× 22 392
YU Jin-hong China 7 160 0.6× 50 0.8× 17 0.3× 26 0.7× 14 0.4× 14 307
Shi Yin Wong Singapore 4 363 1.4× 49 0.8× 22 0.4× 11 0.3× 15 0.4× 9 431
Anna May United Kingdom 6 223 0.8× 38 0.6× 51 0.9× 144 4.1× 15 0.4× 10 462
Juan Camilo Díaz-Coronado Colombia 6 297 1.1× 113 1.9× 10 0.2× 9 0.3× 14 0.4× 18 380
Maher Al Bahrani Oman 6 253 1.0× 142 2.4× 15 0.3× 8 0.2× 13 0.4× 13 296
Abdimadiyeva Aigerim South Korea 7 375 1.4× 118 2.0× 44 0.8× 5 0.1× 16 0.5× 8 441

Countries citing papers authored by Abdulkarim Abdulrahman

Since Specialization
Citations

This map shows the geographic impact of Abdulkarim Abdulrahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulkarim Abdulrahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulkarim Abdulrahman more than expected).

Fields of papers citing papers by Abdulkarim Abdulrahman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdulkarim Abdulrahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulkarim Abdulrahman. The network helps show where Abdulkarim Abdulrahman may publish in the future.

Co-authorship network of co-authors of Abdulkarim Abdulrahman

This figure shows the co-authorship network connecting the top 25 collaborators of Abdulkarim Abdulrahman. A scholar is included among the top collaborators of Abdulkarim Abdulrahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdulkarim Abdulrahman. Abdulkarim Abdulrahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abdulrahman, Abdulkarim, et al.. (2024). A Life-threatening Bradyarrhythmia in the ICU: Beware of Phenytoin Loading!. A3646–A3646.
4.
AlQahtani, Manaf, et al.. (2022). Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease. Scientific Reports. 12(1). 4925–4925. 20 indexed citations
5.
AlQahtani, Manaf, et al.. (2022). Evaluation of Rapid Antigen Tests Using Nasal Samples to Diagnose SARS-CoV-2 in Symptomatic Patients. Frontiers in Public Health. 9. 728969–728969. 14 indexed citations
6.
Abdulrahman, Abdulkarim, et al.. (2022). Real-World Experience with a 60-mm-Long Stent in the Setting of Primary Percutaneous Coronary Intervention. SHILAP Revista de lepidopterología. 23(3). 133–137. 1 indexed citations
7.
Abdulrahman, Abdulkarim, et al.. (2021). The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19. International Journal of Infectious Diseases. 105. 656–661. 46 indexed citations
8.
Abdulrahman, Abdulkarim, et al.. (2021). Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study. SHILAP Revista de lepidopterología. 2(2). 167–174. 10 indexed citations
9.
Miguel, Ana, João Barbosa‐Breda, Luís Filipe Azevedo, et al.. (2021). OCT-angiography detects longitudinal microvascular changes in glaucoma: a systematic review. British Journal of Ophthalmology. 106(5). 667–675. 20 indexed citations
10.
Abdulrahman, Abdulkarim, et al.. (2021). Association between RT-PCR Ct values and COVID-19 new daily cases: a multicenter cross-sectional study. Infezioni in Medicina. 29(3). 416–426. 17 indexed citations
11.
Abdulrahman, Abdulkarim, et al.. (2021). The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort. Infectious Diseases and Therapy. 10(1). 439–455. 7 indexed citations
12.
Abdulrahman, Abdulkarim, et al.. (2021). Influence of COVID-19 Pandemic on Cardiac Services in Bahrain. SHILAP Revista de lepidopterología. 22(3). 174–183. 1 indexed citations
13.
Abdulrahman, Abdulkarim, et al.. (2021). The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes. Scientific Reports. 11(1). 5745–5745. 25 indexed citations
14.
Abdulrahman, Abdulkarim, Saad I. Mallah, & Manaf AlQahtani. (2021). COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study. BMC Infectious Diseases. 21(1). 688–688. 44 indexed citations
15.
Abdulrahman, Abdulkarim, et al.. (2021). Is atrial fibrillation a risk factor for worse outcomes in severe COVID-19 patients: a single center retrospective cohort. Journal of the Saudi Heart Association. 33(2). 160–168. 8 indexed citations
16.
Mallah, Saad I., et al.. (2021). Clinical and Epidemiological Characteristics of COVID-19 in a Multi-National Cohort in the Middle East. Journal of Epidemiology and Global Health. 11(2). 137–137. 2 indexed citations
17.
AlQahtani, Manaf, et al.. (2021). Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease. Scientific Reports. 11(1). 9927–9927. 60 indexed citations
18.
Abdulrahman, Abdulkarim, et al.. (2021). Time Till Viral Clearance of Severe Acute Respiratory Syndrome Coronavirus 2 Is Similar for Asymptomatic and Non-critically Symptomatic Individuals. Frontiers in Medicine. 8. 616927–616927. 10 indexed citations
19.
AlQahtani, Manaf, et al.. (2020). The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects. International Journal of Infectious Diseases. 102. 285–288. 40 indexed citations
20.
Abdulrahman, Abdulkarim, et al.. (2020). COVID-19 and sickle cell disease in Bahrain. International Journal of Infectious Diseases. 101. 14–16. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026